Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,322
Sort by:
Biosimilar Insulin-Asia Pacific Market Status and Trend Report 2013-2023
US$ 3,480.00
... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Biosimilar Insulin market as: Asia Pacific Biosimilar Insulin Market ...
December 2017
135 pages
Biosimilar Insulin-China Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the China Biosimilar Insulin market as: China Biosimilar Insulin Market ...
December 2017
132 pages
Biosimilar Insulin-EMEA Market Status and Trend Report 2013-2023
US$ 3,480.00
Report Summary Biosimilar Insulin-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilar Insulin industry, standing on the readers’ perspective, delivering detailed market data and ...
December 2017
135 pages
Biosimilar Insulin-Europe Market Status and Trend Report 2013-2023
US$ 3,480.00
... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the Europe Biosimilar Insulin market as: Europe Biosimilar Insulin Market ...
December 2017
132 pages
Biosimilar Insulin-India Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the India Biosimilar Insulin market as: India Biosimilar Insulin Market ...
December 2017
130 pages
Biosimilar Insulin-North America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the North America Biosimilar Insulin market as: North America Biosimilar Insulin Market ...
December 2017
154 pages
Biosimilar Insulin-South America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the South America Biosimilar Insulin market as: South America Biosimilar Insulin Market ...
December 2017
158 pages
Biosimilar Insulin-United States Market Status and Trend Report 2013-2023
US$ 3,480.00
... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the United States Biosimilar Insulin market as: United States Biosimilar Insulin Market ...
December 2017
151 pages
Hereceptin Biosimilar-Asia Pacific Market Status and Trend Report 2013-2023
US$ 3,480.00
... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Hereceptin Biosimilar market as: Asia Pacific ...
December 2017
137 pages
Hereceptin Biosimilar-China Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the China Hereceptin Biosimilar market as: China Hereceptin Biosimilar Market ...
December 2017
141 pages
Hereceptin Biosimilar-Europe Market Status and Trend Report 2013-2023
US$ 3,480.00
... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the Europe Hereceptin Biosimilar market as: Europe Hereceptin ...
December 2017
135 pages
Hereceptin Biosimilar-India Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the India Hereceptin Biosimilar market as: India Hereceptin Biosimilar Market ...
December 2017
146 pages
Hereceptin Biosimilar-North America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the North America Hereceptin Biosimilar market as: North America ...
December 2017
154 pages
Hereceptin Biosimilar-South America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the South America Hereceptin Biosimilar market as: South America ...
December 2017
159 pages
Hereceptin Biosimilar-United States Market Status and Trend Report 2013-2023
US$ 3,480.00
... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the United States Hereceptin Biosimilar market as: United States ...
December 2017
133 pages
Asia-Pacific Plant Extracts Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 4,480.00
... Asia-Pacific Plant Extracts market. Chapter 1, to describe Plant Extracts Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Plant Extracts ...
December 2017
116 pages
Influenza Vaccine Market, 2012 to 2023
US$ 4,400.00
... Based on vaccine type, Influenza Vaccines market segmented as follows: Killed or Inactivated Vaccine Live Vaccine Based on strain type, Influenza Vaccines market segmented as follows: Trivalent Influenza Vaccine Quadrivaleant Influenza Vaccine Based on formulation type, Influenza Vaccines market segmented ...
December 2017
210 pages
Autoimmune Disease Diagnostics Market, 2012 to 2023
US$ 4,400.00
... period. Market Scope: Autoimmune Disease Diagnostics Market Global Autoimmune Disease Diagnostics market is segmented based on type, disease and end-user Based on type, global autoimmune disease diagnostics are segmented into Systemic Autoimmune Disease Local Autoimmune Disease Based on disease ...
December 2017
224 pages
EMEA (Europe, Middle East and Africa) Cytokines Market 2017 Forecast to 2022
US$ 4,480.00
... This report focuses on the Cytokines in EMEA (Europe, Middle East and Africa) market, covering Europe, Middle East and Africa, This report categorizes the market ... Arthritis Others There are 13 Chapters to deeply display the EMEA (Europe, Middle East and Africa) Cytokines market. Chapter 1, to describe Cytokines ...
November 2017
124 pages
Bevacizumab Biosimilar-Asia Pacific Market Status and Trend Report 2013-2023
US$ 3,480.00
... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Bevacizumab Biosimilar market as: Asia Pacific ...
November 2017
147 pages
Bevacizumab Biosimilar-China Market Status and Trend Report 2013-2023
US$ 2,980.00
... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the China Bevacizumab Biosimilar market as: China Bevacizumab ...
November 2017
157 pages
Bevacizumab Biosimilar-Europe Market Status and Trend Report 2013-2023
US$ 3,480.00
... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the Europe Bevacizumab Biosimilar market as: Europe Bevacizumab ...
November 2017
133 pages
Bevacizumab Biosimilar-India Market Status and Trend Report 2013-2023
US$ 2,980.00
... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the India Bevacizumab Biosimilar market as: India Bevacizumab ...
November 2017
138 pages
Bevacizumab Biosimilar-North America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the North America Bevacizumab Biosimilar market as: North America Bevacizumab Biosimilar ...
November 2017
135 pages
Bevacizumab Biosimilar-South America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the South America Bevacizumab Biosimilar market as: South America Bevacizumab Biosimilar ...
November 2017
160 pages
Bevacizumab Biosimilar-United States Market Status and Trend Report 2013-2023
US$ 3,480.00
... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the United States Bevacizumab Biosimilar market as: United ...
November 2017
158 pages
Global Blood Grouping Reagents Market, 2012 to 2023
US$ 4,400.00
... reagents globally. Global blood grouping reagent market is segmented on the basis of product, technique, test type, end user, and region. Based on product, global blood grouping reagent market is segmented as : Consumables Instruments Based on technique, global blood grouping reagent market ...
November 2017
211 pages
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Sanger Sequencing Service Market 2017 Forecast to 2022
US$ 4,880.00
... focuses on the Sanger Sequencing Service in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Biotech Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...
November 2017
121 pages
Commercialisaton of Biosimilars: Multifunctional teamwork for success
US$ 2,245.00
... believe companies need to choose 'a road less travelled'? Commercialisation of Biosimilars: Team Tactics & Strategies Across the Product Lifecycle reveals what ... to optimal strategy development and implementation for biosimilars Key insights As the biosimilar market matures, commercial strategies will evolve to ...
October 2017
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Plant Extracts Market 2017 Forecast to 2022
US$ 4,880.00
... report focuses on the Plant Extracts in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Kancor Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia ...
October 2017
116 pages
2017-2022 Global Top Countries DHA from Algae Market Report
US$ 4,960.00
... USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies DHA from Algae in Global market, especially ... , Middle East and Africa, focuses on the top Players in each country, covering DSM Lonza Cellana Daesang JC Biotech BIOCO Cabio Bioengineering ...
October 2017
112 pages
2017-2022 Asia-Pacific Top Countries DHA from Algae Market Report
US$ 4,660.00
... reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies DHA from Algae in Asia-Pacific market, especially in China, ... Countries, this report splits Asia-Pacific into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...
October 2017
112 pages
2017-2022 China DHA from Algae Market Report (Status and Outlook)
US$ 3,360.00
... 2016, the DHA from Algae market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the ... Runke Bioengineering Split by product types/category, covering DHA Powder DHA Oil Split by applications/end use industries, covers ...
October 2017
112 pages
2017-2022 Europe Top Countries DHA from Algae Market Report
US$ 4,660.00
... 2022. This report studies DHA from Algae in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, ... Countries, this report splits Europe into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...
October 2017
112 pages
2017-2022 India DHA from Algae Market Report (Status and Outlook)
US$ 3,360.00
... , the DHA from Algae market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the ... Biotechnology Runke Bioengineering Split by product types/category, covering DHA Powder DHA Oil Split by applications/end use industries, covers ...
October 2017
112 pages
2017-2022 North America DHA from Algae Market Report
US$ 4,660.00
... will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies DHA from Algae in North America market, especially in United States, ... splits North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 (forecast ...
October 2017
112 pages
2017 Top 5 DHA from Algae Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
US$ 4,960.00
... and 2022. This report studies the global DHA from Algae market, especially in North America, Europe ... top 5 DHA from Algae players in each region, with sales, price, revenue and market share from 2012 to 2017, the ... on sales, market share and growth rate of DHA from Algae in each application, can be divided into ...
October 2017
112 pages
2017-2022 United States DHA from Algae Market Report (Status and Outlook)
US$ 3,360.00
... , the DHA from Algae market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, ... Runke Bioengineering Split by product types/category, covering DHA Powder DHA Oil Split by applications/end use industries, covers ...
October 2017
112 pages
Global and Regional Cellulase (CAS 9012-54-8) Market Research Report 2017
US$ 3,500.00
... in that the resulting sugars are decomposed; enzymatic degradation (cellulase) is the most effective means of degrading cellulose into ... type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume ...
October 2017
112 pages
